Adimab
Adimab is a company focused on developing human monoclonal and bispecific antibodies for oncology, immunomodulation, inflammation, neuroscience, and pain.
Currently, there are no issues on this topic.
Find more companies like Adimab
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.